Biochemical and histomorphological study of streptozotocin-induced diabetes mellitus in rabbits

Pakistan Journal of Nutrition

Volumn 7, Issue 2, 2008, Pages 359-364

  Mir, Sajad Hussain ^a   Baqui, Abdul ^a   Bhagat, R C ^a   Darzi, M M ^b   Shah, Abdul Wahid ^a  

^a UNIVERSITY OF KASHMIR   (India)

^b SHER E KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY OF KASHMIR   (India)

Author keywords

Biochemistry and histopathology; Diabetes mellitus; Streptozotocin

Indexed keywords

CREATININE; GLUCOSE; STREPTOZOCIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BRAIN DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIGESTIVE SYSTEM; GLUCOSE BLOOD LEVEL; HEART DISEASE; HISTOPATHOLOGY; LIVER DISEASE; LUNG DISEASE; MALE; NONHUMAN; PANCREAS DISEASE; RABBIT; STREPTOZOCIN DIABETES; UREA BLOOD LEVEL;

ORYCTOLAGUS CUNICULUS;

EID: 41949125702     PISSN: 16805194     EISSN: None     Source Type: Journal    
DOI: 10.3923/pjn.2008.359.364     Document Type: Article

References (35)

1. Alderson, N.L., M.E. Chachich, N. Frizzell, P. Canning, T.O. Metz and A.S. Januszewski, 2004. Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in streptozotocin diabetic rat. Diabetologia, 47: 1385-1395.
2. Anonymous, 2000. Guidelines for care and use of animals in scientific research. Revised Edn., Indian National Scientific Academy, New Delhi.
3. Aybar, M.J., Sanchej Riera An, A. Grau and S.S. Sanchez, 2001. J. Ethnopharmacol., 27: 243-275.
4. Bedoya, F.J., F. Solano and M. Lucas, 1996. N-monomethyl-arginine and nicotinamide prevent streptozotocin-induced double strand DNA break formation in pancreatic rat islets. Experientia, 52: 344-347.
5. Bell, D., A. Collier, D.M. Mathews, E.J. Cooksey, G.J. McHardy and B.F. Clarke, 1988. Are reduced lung volumes in IDDM due to defect in connective tissue? Diabetes, 37: 829-831.
6. Benneth, R.A. and A.E. Pegg, 1981. Alkylation of DNA in rat tissues following administration of streptozotocin. Cancer Res., 41: 2786-2790.
7. Bolzan, A.D. and M.S. Bianchi, 2002. Genotoxicity of streptozotocin. Mutat. Res., 512: 121-134.
8. Bopanna, K.N., J. Kannan, G. Sushma, R. Balaraman and S.P. Rathod, 1997. Antidiabetic and antihyperlipidaemic effects of neem seed kernel powder on alloxan diabetic rabbits. Indian J. Pharmacol., 29: 162-167.
9. Brownlee, M., 2001. Biochemistry and molecular cell biology of diabetic complications. Nature, 414: 813-820.
10. Calabresi, P. and B.A. Chabner, 1985. Antineoplastic agents. In Goodman A, Rail JW (Eds.). The pharmacological basis of therapeutics. 8th Edn. Pergmann Press, New York., 1209-1263.
11. Floretto, P., M.W. Steffes, E.R.D. Sutherland, C.F. Goetz and M. Mauer, 1998. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N. Eng. J. Med., 339: 69-75.
12. Halami, N.S., 1952. Differentiation of two types of basophils in the adenohypophysis of the rat and mouse. Stain Technol., 27: 61-64.
13. Heidland, A., H. Ling, S. Vamvakas and L. Paczek, 1996. Impaired proteolytic activity as a potential cause of progressive renal disease, Miner Electroylyte Metab., 22: 157-161.
14. Hulthen, U.L., A. Cao, J.R. Rumble, M.E. Cooper and C.I. Johnston, 1996. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition and angiotensin II-AT1-receptor blockade. Am. J. Hypertens., 9: 895-901.
15. 14] streptozotocin and its distribution and excretion in the rat. Biochem. J., 142: 673-683.
16. Kedar, P. and C.H. Chakrabarti, 1983. Effects of Jambolan seed treatment on blood sugar, lipids and urea in streptozotocin induced diabetes in rabbits. Indian J. Pharmacol., 27: 135-40.
17. Kume, E., Y. Ohmachi, S. Itagaki, K. Tamura and K. Doi, 1994. Hepatic changes of mice in the subacute phase of streptozotocin-induced diabetes. Exp. Toxicol. Pathol., 46: 368-374.
18. Luna Lee, G., 1968. Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology, (3rd Edn.), McGraw-Hill Book Company, New York.
19. Mitra, S.K., S. Gopumadhavan, T.S. Muralidhar and S.J. Seshadri, 1996. Effect of D-400 a herbomineral formulation on liver glycogen content and microscopic structure of pancreas and liver in streptozotocin-induced diabetes in rats. Indian J. Exp. Biol., 34: 964-967
20. Muranyi, M., M. Fujioka, H.E. QingPing, A. Han, G. Yong, K. Csiszar and Li Ping-An, 2003. Diabetes activates cell death pathway after transient focal cerebral ischemia. Diabetes, 62: 481-486.
21. Oberley, L.W., 1988. Free radicals and diabetes. Free Radic. Biol. Med., 5: 113-124.
22. Okamato, H., 1981. Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin dependent diabetes. Mol. Cell Biochem., 37: 43-61.
23. Papaccio, G., F.A. Pisanti, M.V. Latronico, E. Ammendola and M. Galdieri, 2000. Multiple low dose and single high dose treatments with streptozotocin do not generate nitric oxide. J. Cell Biochem., 77: 82-91.
24. Popov, D. and M. Simionescu, 1997. Alterations of lung structure in experimental diabetes and diabetes associated with hyperlipidaemia in hamsters. Eur. Respir. J., 10: 1850-1858.
25. Prasad, S., 2000. Fundamentals of Biostatistics (Biometry). EMKAY Publications, Delhi.
26. Rabkin, R., P. Schechter, J.D., Shi and G. Boner, 1996. Protein turnover in the hypertrophying kidney. Miner Electroylyte Metab., 22: 153-156.
27. Rasch, R., 1980. Prevention of diabetic glamerulopathy in streptozotocin diabetic rats by insulin treatment. Diabetologia, 16: 319-324.
28. Sheila Sherlock and James Dooley, 1993. Diseases of the liver and biliary system. Oxford Blackwell Scientific Publications, pp: 414.
29. Shenoy, A.G. and K.G. Ramesh, 2002. Improvement of insulin sensitivity by perindopril in spontaneously hypertensive and streptozotocin-diabetic rats. Ind. J. Pharmacol., 34: 156-164.
30. Sicor Pharmaceuticals, 2003. Material Safety Data Sheet. Sicor Pharmaceuticals Inc. Irvine CA.
31. Szaleczky, E., J. Prechl, J. Feher and A. Samogyi, 1999. Alterations in enzymatic antioxidant defence in diabetes mellitus - a rational approach. Postgrad. Med. J., 75: 13-17.
32. Szkudelski, T., 2001. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res., 50: 536-546.
33. Tawfeeg, A.O. Najjar and Sherif Y. Saad, 2001. Cisplastin pharmacokinetics and its nephrotoxicity in diabetic rabbits. Int. J. Exp. Chemotherapy, 47: 128-135.
34. Weir, G.C., E.T. Clore, C.J. Zmachinski and S. Bonner-Weir, 1981. Islet secretion in a new experiment model for non-insulin dependent diabetes. Diabetes, 30: 590-595.
35. West, E., O.R. Simon and, E.Y. Morrison, 1996. Streptozotocin alters pancreatic beta-cell responsiveness to glucose within six hours of injection into rats. West Ind. Med. J., 45: 60-62.